Skip to main content
. 2018 Jul 19;12:487. doi: 10.3389/fnins.2018.00487

FIGURE 2.

FIGURE 2

MVs and EXOs abundance do not differ between ALS patients and controls. NTA was performed on MVs and EXOs extracted from plasma of healthy controls and ALS patients (n = 20 per group). When averaged, the concentration of MVs (A) and EXOs (B) was not significantly different between the two groups (for MVs CTRLs 4.14 ×1010± 1.18 × 1010 vs. ALS 3.72 × 1010 ± 5.44 × 109 particles/mL and for EXOs CTRLs 3.05 ×1010± 7.40 × 109 vs. ALS 3.35 × 1010 ± 4.96 × 109 particles/mL).